
Inventiva S.A. IVA
$ 6.14
0.9%
Annual report 2024
added 03-07-2026
Inventiva S.A. ROA Ratio 2011-2026 | IVA
Annual ROA Ratio Inventiva S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -40.69 | -24.2 | -53.05 | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -24.2 | -53.05 | -39.31 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
-10.79 | $ 3.55 | -0.42 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
-27.92 | $ 3.25 | 3.83 % | $ 229 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-101.11 | - | 10.36 % | $ 9.8 M | ||
|
Aptorum Group Limited
APM
|
-26.46 | $ 0.79 | 0.04 % | $ 4.31 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
-37.22 | $ 4.12 | -1.9 % | $ 105 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-24.26 | $ 6.52 | -1.66 % | $ 179 M | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
argenx SE
ARGX
|
-14.32 | $ 709.0 | 0.81 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
-35.36 | $ 229.5 | -0.66 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.43 | -4.99 % | $ 8.25 B | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
-50.23 | $ 6.08 | 0.41 % | $ 495 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
-144.48 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | ||
|
Anika Therapeutics
ANIK
|
-30.55 | $ 14.54 | 1.25 % | $ 213 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
BioCardia
BCDA
|
-387.38 | $ 1.3 | 2.36 % | $ 27.5 M | ||
|
Aptose Biosciences
APTO
|
-251.11 | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-50.64 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-10.92 | $ 2.59 | -1.79 % | $ 16.3 M | ||
|
Avenue Therapeutics
ATXI
|
-437.72 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-28.19 | $ 1.51 | -0.33 % | $ 385 M | ||
|
Athira Pharma
ATHA
|
-164.92 | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
65.02 | $ 94.8 | 4.71 % | $ 27.2 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
Burford Capital Limited
BUR
|
5.51 | $ 8.29 | 2.79 % | $ 1.34 B | ||
|
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
-49.73 | $ 1.15 | 3.6 % | $ 34.6 M |